NCT02059421

Brief Summary

The purpose of this project is to compare the effectiveness of Johrei therapy (JT) and Cognitive-behavioral Therapy for Insomnia (CBT-I) in the treatment of sleep disturbances in survivors of critical illness. Subjects will be recruited following discharge from the Intensive Care Unit (ICU) and followed for 6 weeks. All subjects will undergo objective measurements of sleep quality and duration at baseline and at 6 weeks. Objective measurements will be made by portable (home-based) sleep studies and will wear a watch that measures sleep. Subjective measurements will be performed by sleep questionnaires: PSQI, Epworth sleepiness scale, sleep log, and Stanford Sleepiness Scale which will be performed at baseline, 2 and 6 weeks. A blood draw and urine collection will be done at both baseline and 6 weeks. The central purpose of this proposal is to perform a comparative-effectiveness study of a complementary and alternative approach (Johrei therapy) and CBT-I in the treatment of sleep disturbances in survivors of critical illness. The investigators hypothesize that, in survivors of critical illness, Johrei therapy is superior or comparable to CBT-I in improving sleep quality (Pittsburgh Sleep Quality Index \[PSQI\] and sleep efficiency \[measured by polysomnography\]). A secondary objective is to compare the effect of Johrei therapy and CBT-I on systemic markers of inflammation and urinary biomarkers of sleep and stress. The investigators hypothesize that, in survivors of critical illness, Johrei therapy is superior or comparable to CBT-I in reducing systemic markers of inflammation and urinary biomarkers of sleep and stress. A tertiary objective is to determine whether the presence of insomnia or other sleep characteristics is associated with hospital readmissions within 30-days.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 6, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 11, 2014

Completed
9.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

9.4 years

First QC Date

February 6, 2014

Last Update Submit

April 15, 2025

Conditions

Keywords

Johrei therapySleepCBT-ICritical illness

Outcome Measures

Primary Outcomes (3)

  • Pittsburgh Sleep Quality Index (PSQI) (CBT-I, Johrei therapy)

    Used to measure sleep quality

    2 weeks

  • Polysomnography (CBT-I, Johrei therapy)

    Used to measure sleep efficiency

    6 weeks

  • Pittsburgh Sleep Quality Index (PSQI) (CBT-I, Johrei therapy)

    Used to measure sleep quality.

    6 weeks

Secondary Outcomes (9)

  • Actigraphy (CBT-I, Johrei therapy)

    Baseline, 2 weeks, 6 weeks

  • Epworth Sleepiness Scale (ESS) (CBT-I, Johrei therapy)

    Baseline, 2 weeks, 6 weeks

  • Sleep Log (CBT-I, Johrei therapy)

    Baseline, 2 weeks, 6 weeks

  • Stanford Sleepiness Scale (SSS) (CBT-I, Johrei therapy)

    Baseline, 2 weeks, 6 weeks

  • Post Traumatic Stress Disorder (PTSD) Checklist (CBT-I, Johrei therapy)

    Baseline, 2 weeks, 6 weeks

  • +4 more secondary outcomes

Study Arms (2)

Johrei Therapy

EXPERIMENTAL

* 3 sessions per week lasting 30 minutes. * Daily report of bedtime and wake time. Baseline: * Polysomnography * Actigraphy * Questionnaires * Blood draw * Urine collection 2 weeks: * Questionnaires * Actigraphy download * Sleep log reconciliation 6 weeks: * Polysomnography * Actigraphy download * sleep log reconciliation * Questionnaires * Blood draw * Urine collection

Other: Johrei therapy

Cognitive Behavioral Therapy for Insomnia (CBT-I)

ACTIVE COMPARATOR

* 1 session per week for a total of 6 weeks with the option of 2 additional sessions. * Daily report of bedtime and wake time. Baseline: * Polysomnography * Actigraphy * Questionnaires * Blood draw * Urine collection 2 weeks: * Questionnaires * Actigraphy download * Sleep log reconciliation 6 weeks: * Polysomnography * Actigraphy download * sleep log reconciliation * Questionnaires * Blood draw * Urine collection

Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I)

Interventions

\- Therapy session administered by a clinical psychologist using web-based video conferencing software. Therapy sessions will include: * Sleep restriction therapy * Stimulus control instructions * Sleep hygiene education

Cognitive Behavioral Therapy for Insomnia (CBT-I)

* Therapy will be administered by a senior Johrei administrator at the University of Arizona or the patient's residence. * Therapy sessions will consist of 3 sessions per week lasting 30 minutes each. * Therapist will wash his hands and and pray for 1 minute while facing the subject at a distance. * Therapy will be administered without physical contact. * During therapy the administrator will sit adjacent to the patient and channel energy from his palm towards the patient.

Johrei Therapy

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Medical and surgical patients with recent critical illness warranting ICU stay.

You may not qualify if:

  • Patients who are considered too unstable to undergo this investigation by their primary physician
  • Patients with severe debilitating neurological disease ( end-stage Alzheimer's, large stroke, or other debilitating neurological disease) that renders patients incapable of providing informed consent
  • Pregnancy (All inpatients with recent ICU stay of the childbearing age would have had a pregnancy test while in the hospital).
  • Patient's residence is beyond a 20 mile radius from University of Arizona.
  • Patient does not have a reliable way of communication such as a cellphone or telephone line.
  • Being discharged to a nursing home of skilled nursing facility.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arizona Medical Center

Tucson, Arizona, 85724, United States

Location

Related Publications (1)

  • Buzzetti RA, Hinojosa-Kurtzberg M, Shea TJ, Ibuki Y, Sirakis G, Parthasarathy S. Effect of Johrei therapy on sleep in a murine model. Explore (NY). 2013 Mar-Apr;9(2):100-5. doi: 10.1016/j.explore.2012.12.004.

    PMID: 23452712BACKGROUND

MeSH Terms

Conditions

Critical Illness

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Sairam Parthasarathy, MD

    University of Arizona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2014

First Posted

February 11, 2014

Study Start

January 1, 2014

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

April 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD information.

Locations